• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内在免疫原性是新冠病毒感染中型特异性反应的主要决定因素。

Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections.

作者信息

Quirk Grace E, Schoenle Marta V, Peyton Kameron L, Uhrlaub Jennifer L, Lau Branden, Liang Chieh-Yu, Burgess Jefferey L, Ellingson Katherine, Beitel Shawn, Romine James, Lutrick Karen, Fowlkes Ashley, Britton Amadea, Tyner Harmony L, Caban-Martinez Alberto J, Naleway Allison, Gaglani Manjusha, Yoon Sarang, Edwards Laura J, Olsho Lauren, Dake Michael, Valdez Riccardo, Gordon Aubree, Diamond Michael S, LaFleur Bonnie J, Nikolich Janko Ž, Sprissler Ryan, Worobey Michael, Bhattacharya Deepta

机构信息

Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, USA.

Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA.

出版信息

Nat Immunol. 2025 May 27. doi: 10.1038/s41590-025-02162-2.

DOI:10.1038/s41590-025-02162-2
PMID:40425779
Abstract

Few type-specific antibodies that recognize drifted epitopes are made during post-vaccination exposures to SARS-CoV-2 variants, perhaps due to suppression by previous immunity. We compared type-specific B cell responses in unvaccinated and vaccinated individuals with Delta and Omicron BA.1 SARS-CoV-2 variant infections. For both Delta, which is antigenically similar to the vaccine strain, and the more distant BA.1 variant, neutralizing antibodies were greater in post-vaccination variant infections than in primary variant infections. Delta type-specific memory B cells were reduced in post-vaccination Delta infections relative to primary variant infections. Yet some drifted epitopes in the Delta variant elicited minimal responses even in primary infections. For BA.1 infections, type-specific antibodies and memory B cells were mostly undetectable, irrespective of previous immunity. Thus, poor intrinsic antigenicity of drifted epitopes in Delta and BA.1 infections superseded the impact of previous immunity. Enhancing the immunogenicity of vaccine antigens may promote type-specific responses.

摘要

在接种疫苗后接触新冠病毒变种期间,很少产生识别发生抗原漂移表位的型特异性抗体,这可能是由于先前免疫的抑制作用。我们比较了未接种疫苗和接种疫苗的个体感染德尔塔和奥密克戎BA.1新冠病毒变种时的型特异性B细胞反应。对于抗原性与疫苗株相似的德尔塔以及亲缘关系更远的BA.1变种,接种疫苗后感染变种时产生的中和抗体比初次感染变种时更多。与初次感染变种相比,接种疫苗后感染德尔塔时,德尔塔型特异性记忆B细胞减少。然而,即使在初次感染中,德尔塔变种中的一些发生抗原漂移的表位引发的反应也很微弱。对于BA.1感染,无论先前是否有免疫力,型特异性抗体和记忆B细胞大多无法检测到。因此,德尔塔和BA.1感染中发生抗原漂移表位的固有抗原性较差,超过了先前免疫的影响。增强疫苗抗原的免疫原性可能会促进型特异性反应。

相似文献

1
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections.内在免疫原性是新冠病毒感染中型特异性反应的主要决定因素。
Nat Immunol. 2025 May 27. doi: 10.1038/s41590-025-02162-2.
2
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study.一种单价奥密克戎XBB.1.5 SARS-CoV-2重组刺突蛋白疫苗在既往未接种过疫苗、SARS-CoV-2血清阳性参与者中的免疫原性和安全性:一项2/3期开放标签研究的第28天初步分析
Vaccine. 2025 May 10;55:127046. doi: 10.1016/j.vaccine.2025.127046. Epub 2025 Apr 2.
3
Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis.慢性淋巴细胞白血病患者中SARS-CoV-2疫苗接种的免疫反应动力学:一项描述性分析
Front Immunol. 2025 Jun 6;16:1571680. doi: 10.3389/fimmu.2025.1571680. eCollection 2025.
4
Determinants of B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections.接种疫苗后感染新冠病毒时B细胞对漂移表位反应的决定因素
medRxiv. 2023 Sep 14:2023.09.12.23295384. doi: 10.1101/2023.09.12.23295384.
5
Long-term Response to SARS-CoV-2 mRNA Vaccine in Adolescents.青少年对SARS-CoV-2 mRNA疫苗的长期反应
Pediatr Infect Dis J. 2025 Jun 1;44(6):550-556. doi: 10.1097/INF.0000000000004709. Epub 2025 Jan 28.
6
Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults.单剂量SpikoGen®疫苗作为异源或同源肌肉注射加强针,在门诊成人中于mRNA、腺病毒载体或重组蛋白COVID-19疫苗初免后进行的免疫原性和安全性研究。
Vaccine. 2025 Mar 7;49:126744. doi: 10.1016/j.vaccine.2025.126744. Epub 2025 Feb 5.
7
Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine doses.早期接种mRNA疫苗后,佐剂重组SARS-CoV-2刺突蛋白疫苗的免疫原性。
J Allergy Clin Immunol. 2025 Jun;155(6):2063-2074.e6. doi: 10.1016/j.jaci.2025.03.015. Epub 2025 Mar 26.
8
Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia.哥伦比亚对新冠病毒疫苗接种特异性抗体反应的纵向随访
J Med Virol. 2025 Jan;97(1):e70133. doi: 10.1002/jmv.70133.
9
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
10
Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer.头颈癌患者对新型冠状病毒的体液免疫和细胞免疫反应
Viruses. 2025 Jun 13;17(6):848. doi: 10.3390/v17060848.

引用本文的文献

1
Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history.具有不同疫苗接种史的小鼠中,单价和多价亚单位疫苗针对新冠病毒变异株的免疫原性。
Microbiol Spectr. 2025 Jul 17:e0290724. doi: 10.1128/spectrum.02907-24.

本文引用的文献

1
Vaccination against rapidly evolving pathogens and the entanglements of memory.针对快速进化病原体的疫苗接种和记忆的纠缠。
Nat Immunol. 2024 Nov;25(11):2015-2023. doi: 10.1038/s41590-024-01970-2. Epub 2024 Oct 9.
2
Conversion of vaccines from low to high immunogenicity by antibodies with epitope complementarity.通过具有表位互补性的抗体将疫苗从低免疫原性转化为高免疫原性。
Immunity. 2024 Oct 8;57(10):2433-2452.e7. doi: 10.1016/j.immuni.2024.08.017. Epub 2024 Sep 20.
3
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals.
镶嵌沙贝科病毒纳米颗粒在预先接种疫苗的动物中引发交叉反应性应答。
Cell. 2024 Oct 3;187(20):5554-5571.e19. doi: 10.1016/j.cell.2024.07.052. Epub 2024 Aug 27.
4
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.武汉-1 mRNA 疫苗对血清中和抗体的印迹作用。
Nature. 2024 Jun;630(8018):950-960. doi: 10.1038/s41586-024-07539-1. Epub 2024 May 15.
5
Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin.接种疫苗会损害针对奥密克戎突破性感染的新免疫反应,这是原始抗原性错误的前提条件。
Nat Commun. 2024 Apr 10;15(1):3102. doi: 10.1038/s41467-024-47451-w.
6
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans.接种 COVID-19 XBB.1.5 mRNA 加强针后,人体会持续产生免疫印记。
Immunity. 2024 Apr 9;57(4):904-911.e4. doi: 10.1016/j.immuni.2024.02.016. Epub 2024 Mar 14.
7
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.SARS-CoV-2 奥密克戎亚变种的受体结合域靶向 Siglec-9,通过阻止巨噬细胞吞噬作用降低其免疫原性。
Nat Immunol. 2024 Apr;25(4):622-632. doi: 10.1038/s41590-024-01776-2. Epub 2024 Mar 7.
8
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.多次感染奥密克戎会颠覆原始 SARS-CoV-2 免疫印记。
Nature. 2024 Jan;625(7993):148-156. doi: 10.1038/s41586-023-06753-7. Epub 2023 Nov 22.
9
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.COVID 研究促进康复(RECOVER)成人研究方案:原理、目标和设计。
PLoS One. 2023 Jun 23;18(6):e0286297. doi: 10.1371/journal.pone.0286297. eCollection 2023.
10
Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants.新冠病毒变异株在宿主内的连续进化和传播。
Nat Commun. 2023 Jun 3;14(1):3235. doi: 10.1038/s41467-023-38867-x.